ASML 2Q25 Earnings Review

Key Observation 

ASML's 2Q25 earnings report presents a stark contrast between strong current performance and cautious forward guidance. This quarter's results comprehensively exceeded market expectations and the company's own guidance, with total net sales of €7.69 billion (vs. con. €7.51 billion) and a gross margin as high as 53.7% (vs. con. 51.9%). This strong performance was primarily driven by higher-margin upgrade services and one-off cost savings. Net bookings rebounded strongly to €5.54 billion, significantly above the market consensus of €4.8 billion, demonstrating the resilience of current demand.

However, the most critical signal from this earnings report and conference call is management's prudent stance on the future outlook. The company's Q3 revenue guidance mid-point (€7.65 billion) is below the market consensus of €8.21 billion. Furthermore, the CEO, for the first time in official statements and conference calls, repeatedly emphasized that due to increasing uncertainties from macroeconomic conditions and geopolitical factors (especially potential tariff issues), it is currently unable to confirm growth for 2026. This cautious long-term outlook directly addresses and confirms the widespread concerns about mid-term growth highlighted by sell-side analysts in their earnings previews, forming the focal point of this earnings report and the core of analysts' repeated questions during the earnings call Q&A session.

Sell-side analysts generally believe that despite ASML's strong performance in revenue, gross margin, and bookings (especially for EUV and High NA EUV), and its maintenance of full-year growth guidance for 2025, the company's uncertainty regarding the 2026 growth outlook (downgraded from "able to confirm growth" to "unable to confirm growth") has raised widespread market concerns. This uncertainty primarily stems from macroeconomic conditions, geopolitical factors (such as tariffs), and challenges faced by some key customers (such as Intel and Samsung). Analysts have generally lowered their 2026/2027 earnings forecasts and target prices for ASML. Nevertheless, most institutions (e.g., Bank of America, Goldman Sachs, BNP Paribas, Citi) have maintained Buy or Outperform ratings, based on ASML's long-term technological leadership and growth potential in High NA EUV, AI demand, and the DRAM market. Only Bernstein & MS hold a more pessimistic "Market-Perform" rating due to concerns about its long-term prospects and valuation premium. The China market remains a significant contributor to revenue in the short term, but its long-term evolution is subject to uncertainty.